Literature DB >> 22263593

Vasorelaxant effect of formononetin in the rat thoracic aorta and its mechanisms.

Yan Zhao1, Bai-Nian Chen, Shou-Bao Wang, Shao-Hua Wang, Guan-Hua Du.   

Abstract

The purpose of the present study was to investigate the effect of formononetin and the related mechanisms on isolated rat thoracic aorta. Formononetin concentration dependently relaxed aortic rings precontracted with norepinephrine (NE, 1 μM) or KCl (80 mM). Pretreatment with formononetin noncompetitively inhibited contractile responses of aortas to NE and KCl. The vasorelaxant effect of formononetin partially relied on intact endothelia, which was significantly attenuated by incubation with N(ω)-nitro-L-arginine methyl ester (100 μM). In endothelium-denuded rings, glibenclamide (10 μM) and tetraethylammonium (5 mM) showed slight reduction in the vasorelaxant effect of formononetin. Moreover, formononetin reduced NE-induced transient contraction in Ca²⁺-free solution and inhibited the vasocontraction induced by increasing external calcium in medium plus 80 mM KCl. Our results suggested that formononetin induced relaxation in rat aortic rings through an endothelium-dependent manner via nitric oxide synthesis pathway, and also involving an endothelium-independent vasodilatation by the blockade of Ca²⁺ channels. The opening of K⁺ channels might also be one of the mechanisms of formononetin-induced vasorelaxation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22263593     DOI: 10.1080/10286020.2011.628939

Source DB:  PubMed          Journal:  J Asian Nat Prod Res        ISSN: 1028-6020            Impact factor:   1.569


  8 in total

1.  Calycosin and Formononetin Induce Endothelium-Dependent Vasodilation by the Activation of Large-Conductance Ca2+-Activated K+ Channels (BKCa).

Authors:  Hisa Hui Ling Tseng; Chi Teng Vong; George Pak-Heng Leung; Sai Wang Seto; Yiu Wa Kwan; Simon Ming-Yuen Lee; Maggie Pui Man Hoi
Journal:  Evid Based Complement Alternat Med       Date:  2016-11-23       Impact factor: 2.629

Review 2.  Vasodilator compounds derived from plants and their mechanisms of action.

Authors:  Francisco J Luna-Vázquez; César Ibarra-Alvarado; Alejandra Rojas-Molina; Isela Rojas-Molina; Miguel Angel Zavala-Sánchez
Journal:  Molecules       Date:  2013-05-17       Impact factor: 4.411

3.  Formononetin induces vasorelaxation in rat thoracic aorta via regulation of the PI3K/PTEN/Akt signaling pathway.

Authors:  Teng Li; Yuanyuan Zhong; Tao Tang; Jiekun Luo; Hanjin Cui; Rong Fan; Yang Wang; Dongsheng Wang
Journal:  Drug Des Devel Ther       Date:  2018-11-01       Impact factor: 4.162

Review 4.  The Vascular Effects of Isolated Isoflavones-A Focus on the Determinants of Blood Pressure Regulation.

Authors:  Henrique Silva
Journal:  Biology (Basel)       Date:  2021-01-12

5.  A Novel Formononetin Derivative Promotes Anti-ischemic Effects on Acute Ischemic Injury in Mice.

Authors:  Lin Zhao; Jing Han; Jiaqi Liu; Kechen Fan; Tianjie Yuan; Ju Han; Liangliang Chen; Sen Zhang; Ming Zhao; Jinao Duan
Journal:  Front Microbiol       Date:  2021-12-14       Impact factor: 5.640

6.  A novel piperidine identified by stem cell-based screening attenuates pulmonary arterial hypertension by regulating BMP2 and PTGS2 levels.

Authors:  Yanjiang Xing; Shuang Zhao; Qingxia Wei; Shiqiang Gong; Xin Zhao; Fang Zhou; Rafia Ai-Lamki; Daniel Ortmann; Mingxia Du; Roger Pedersen; Guangdong Shang; Shuyi Si; Nicholas W Morrell; Jun Yang
Journal:  Eur Respir J       Date:  2018-04-04       Impact factor: 16.671

Review 7.  Potential Benefits of Flavonoids on the Progression of Atherosclerosis by Their Effect on Vascular Smooth Muscle Excitability.

Authors:  Rosa Edith Grijalva-Guiza; Aura Matilde Jiménez-Garduño; Luis Ricardo Hernández
Journal:  Molecules       Date:  2021-06-10       Impact factor: 4.411

8.  Interaction of Isoflavones and Endophyte-Infected Tall Fescue Seed Extract on Vasoactivity of Bovine Mesenteric Vasculature.

Authors:  Yang Jia; David L Harmon; Michael D Flythe; James L Klotz
Journal:  Front Nutr       Date:  2015-10-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.